NEOPLASMS, PANCREATIC
Clinical trials for NEOPLASMS, PANCREATIC explained in plain language.
Never miss a new study
Get alerted when new NEOPLASMS, PANCREATIC trials appear
Sign up with your email to follow new studies for NEOPLASMS, PANCREATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a pill rouse the immune system against pancreatic cancer?
Disease control TerminatedThis early-phase trial is testing whether an experimental oral drug called BXCL701 can change how the immune system responds to pancreatic cancer. The study will enroll people with untreated, locally advanced or metastatic pancreatic cancer who can undergo tumor biopsies before a…
Matched conditions: NEOPLASMS, PANCREATIC
Phase: EARLY_PHASE1 • Sponsor: BioXcel Therapeutics Inc • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
New drug shows promise for stubborn cancers
Disease control OngoingThis study tests a new drug called 9-ING-41, given alone or with chemotherapy, in adults with cancers that have not responded to standard treatments. The goal is to see if the drug is safe and can help control the disease. About 350 people with various advanced cancers, including…
Matched conditions: NEOPLASMS, PANCREATIC
Phase: PHASE2 • Sponsor: Actuate Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New cocktail of targeted drugs and chemo takes on pancreatic cancer
Disease control OngoingThis study tests whether adding two targeted drugs (avutometinib and defactinib) to standard chemotherapy can help people with metastatic pancreatic cancer that hasn't been treated yet. About 40 adults with this cancer will receive the combination. The goal is to find the safest …
Matched conditions: NEOPLASMS, PANCREATIC
Phase: PHASE1, PHASE2 • Sponsor: Verastem, Inc. • Aim: Disease control
Last updated Jun 26, 2026 13:18 UTC